ATI and Bruker Announce Agreement to Further Advance Niobium-Based Superconductor Technology and Manufacturing Processes
November 26 2018 - 8:00AM
Business Wire
Allegheny Technologies Incorporated (NYSE: ATI) and Bruker
Energy & Supercon Technologies (BEST), a wholly owned
subsidiary of Bruker Corporation, today announced that they have
entered into a joint technology development agreement to advance
state-of-the-art niobium-based superconductors, including those
used in magnetic resonance imaging (MRI) magnets for the medical
industry, and preclinical MRI magnets used in the life-science
tools industry.
Built on a 30-year collaboration between the two companies, this
agreement further extends their tremendous combined expertise to
develop higher-performance niobium-based alloys and apply these
alloys in improved and more efficient superconductors, which are
expected to enable MRI magnets with higher performance and lower
total cost of ownership. The resulting products are expected to
have applications in medical imaging, scientific instrumentation,
particle physics research, and large-scale fusion experiments to
produce energy. The advanced manufacturing and metrology processes,
as well as the highly differentiated new superconductors planned
under this agreement will deliver higher performance, ultimately
aiming to give healthcare providers better diagnostics to improve
lives. At the same time, the fully integrated supply chain will
allow for process innovation to even further increase efficiency,
quality and supply chain security for demanding customers.
Bruker Energy & Supercon Technologies is a leading
manufacturer of highest performance superconducting wire products
with a product portfolio that includes high-quality niobium-based
superconductors. With more than 50 years of experience in the field
of superconducting wire, BEST offers a unique and broad
superconductor technology spectrum, a highly automated
superconductor factory with the most advanced and integrated
metrology capabilities to ensure highest conductor yield, quality
and on-time deliveries. BEST has invested heavily in these unique
capabilities over the last decade in order to meet a wide range of
requirements for healthcare, industrial and research
applications.
“This long-term agreement further strengthens the extensive
cooperation between ATI and Bruker,” commented Dr. Burkhard Prause,
President of BEST. “We believe this collaboration will further
advance the combined expertise within our businesses to create new
and improved superconductor products and deliver enhanced
commercial value for our healthcare and life science
customers.”
ATI, a global leader in refractory metal production and
manufacturer of specialty alloys, materials, and components, brings
more than 50 years of experience as a leading manufacturer of
niobium-titanium and other specialty alloys for medical and
high-energy physics applications. “ATI has long led the industry
with its technical expertise and differentiated manufacturing
capability for niobium-based alloys for superconductors,” said Lee
Weber, President of ATI Specialty Alloys and Components. “This new
agreement expands our collaboration, so we may create the specialty
materials that will propel the industry. The Relentless Innovation™
for which ATI is known is truly saving lives and improving the
future for generations to come.”
Forward-Looking Statements
This news release contains “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of
1995. Certain statements in this news release relate to future
events and expectations and, as such, constitute forward-looking
statements. Forward-looking statements, which may contain such
words as “anticipates,” “believes,” “estimates,” “expects,”
“would,” “should,” “will,” “will likely result,” “forecast,”
“outlook,” “projects,” and similar expressions, are based on
management’s current expectations and include known and unknown
risks, uncertainties and other factors, many of which we are unable
to predict or control. Our performance or achievements may differ
materially from those expressed or implied in any forward-looking
statements due to the following factors, among others: (a) material
adverse changes in economic or industry conditions generally,
including global supply and demand conditions and prices for our
specialty metals; (b) material adverse changes in the markets we
serve; (c) our inability to achieve the level of cost savings,
productivity improvements, synergies, growth or other benefits
anticipated by management from strategic investments and the
integration of acquired businesses; (d) volatility in the price and
availability of the raw materials that are critical to the
manufacture of our products; (e) declines in the value of our
defined benefit pension plan assets or unfavorable changes in laws
or regulations that govern pension plan funding; (f) labor
disputes or work stoppages; (g) equipment outages and (h) other
risk factors summarized in our Annual Report on Form 10-K for the
year ended December 31, 2017, and in other reports filed with the
Securities and Exchange Commission. We assume no duty to update our
forward-looking statements.
About Bruker Corporation
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
Creating Value Thru Relentless Innovation™
ATI is a global manufacturer of technically advanced specialty
materials and complex components. ATI revenue was $3.9
billion for the twelve-month period ended September 30, 2018.
Our largest markets are aerospace & defense, particularly jet
engines. We also have a strong presence in the oil & gas,
electrical energy, medical, automotive, and other industrial
markets. ATI is a market leader in manufacturing differentiated
specialty alloys and forgings that require our unique manufacturing
and precision machining capabilities and our innovative new product
development competence. We are a leader in producing powders for
use in next-generation jet engine forgings and 3D-printed aerospace
products. See more at our website ATIMetals.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181126005381/en/
Allegheny Technologies IncorporatedInvestor Contact:Scott A.
Minder, 412-395-2720scott.minder@atimetals.com
Media Contact:Natalie Gillespie, 412-394-2850Vice
President,
Communicationsnatalie.gillespie@atimetals.comwww.ATImetals.com
Bruker Energy & Supercon Technologies, Inc.Jeff Parrell,
Ph.D., +1-732-541-1300Senior Vice
Presidentjeffrey.parrell@bruker.com
ATI (NYSE:ATI)
Historical Stock Chart
From Aug 2024 to Sep 2024
ATI (NYSE:ATI)
Historical Stock Chart
From Sep 2023 to Sep 2024